Standout Papers

Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis 1999 2026 2008 2017 959
  1. Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis (1999)
    Bonnie W. Ramsey, Margaret S. Pepe et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 15 from Science/Nature 102 standout
Sub-graph 1 of 15

Citing Papers

The extracellular matrix and the immune system: A mutually dependent relationship
2023 StandoutScience
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist
2023 Standout
51 intermediate papers

Works of Kelly Otto being referenced

Determination of the Minimal Clinically Important Difference Scores for the Cystic Fibrosis Questionnaire-Revised Respiratory Symptom Scale in Two Populations of Patients With Cystic Fibrosis and Chronic Pseudomonas aeruginosa Airway Infection
2009
Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis
1999 Standout
and 4 more

Author Peers

Author Last Decade Papers Cites
Kelly Otto 1651 387 134 260 10 1.9k
Joanne Quan 1915 547 134 250 17 2.5k
Judy Williams‐Warren 1926 565 172 286 26 2.3k
Rosemary Carzino 1891 452 103 472 38 2.3k
Preston W. Campbell 2281 443 110 343 36 2.9k
Peter Hiatt 2066 761 114 539 33 2.6k
Lynne M. Quittell 1910 283 65 514 27 2.4k
Elliott C. Dasenbrook 1248 355 111 341 36 1.6k
D. Elizabeth Tullis 941 330 46 469 34 1.6k
Leslie Hazle 1265 290 58 187 5 1.4k
Susan G. Marshall 1068 274 80 156 28 1.8k

All Works

Loading papers...

Rankless by CCL
2026